School Of Medicine 9
401. Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019
402. Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019
403. Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019
404. Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019
405. Digitalization of health care in low- and middle-income countries
406. The Responsible Health AI Readiness and Maturity Index (RHAMI): Applications for a Global Narrative Review of Leading AI Use Cases in Public Health Nutrition
407. A Multinational Randomized Trial of Mega-Dose Esomeprazole As Anti-Inflammatory Agent in Sepsis
408. Early noninvasive ventilation in general wards for acute respiratory failure: an international, multicentre, open-label, randomised trial
409. Pirfenidone to prevent fibrosis in acute respiratory distress syndrome: The PIONEER study protocol
410. Role of periostin in inflammatory bowel disease development and synergistic effects mediated by the CCL5–CCR5 axis
411. Genetic variations influencing glucose homeostasis and insulin secretion and their associations with autism spectrum disorder in kazakhstan
412. Micellization Behavior and Thermodynamic Characteristics of Saponin and SDS: The Impact of Silica Nanoparticles for Subsurface Formation Interaction Studies
413. Diagnostic Delay in Patients With Chronic Urticaria: Results From the Chronic Urticaria Registry (CURE)
414. Paucity of Health Data in Africa: An Obstacle to Digital Health Implementation and Evidence-Based Practice
415. Socioeconomic disparities in physical activity, sedentary behavior and sleep patterns among 6- to 9-year-old children from 24 countries in the WHO European region
416. Comparative Chloroplast Genomics of Calligonum leucocladum from Kazakhstan: Genetic Basis for Arid Adaptation and Agroforestry Applications
417. Knowledge, Attitudes, and Practices of Sun Exposure and Sun Protection among the Population of Kazakhstan: A Cross Sectional Study
418. Digging into the Solubility Factor in Cancer Diagnosis: A Case of Soluble CD44 Protein
419. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
420. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
421. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
422. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
423. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
424. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
425. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
426. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
427. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
428. Deer antler extract-nanoparticles exhibit co-nanozyme activity and targeting of prostate cancer cells
429. Light controllable smart Poly(ADP-ribose) polymerase-1 inhibitor delivery by sustainable green materials for regulation of cytotoxicity
430. Simulation-based training in minimally invasive surgical therapies (MIST): current evidence and future directions for artificial intelligence integration—a systematic review by EAU endourology
431. Developing a guide for international course alignment: lessons learned from an integrated curriculum design
432. Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology
433. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
434. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
435. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
436. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
437. National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050
438. National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050
439. National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050
440. National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050
441. National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050
442. National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050
443. National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050
444. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
445. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
446. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
447. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
448. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
449. Global mortality from dementia: Application of a newmethod and results from the global burden of disease study 2019
450. Global mortality from dementia: Application of a newmethod and results from the global burden of disease study 2019
1 7 8 9 10 11 15